A Modified Phase I/II Trial Of Rapamycin In Patients With Glioblastoma Multiforme
Phase of Trial: Phase I/II
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Sirolimus (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2009 Actual end date (Oct 2007) and actual number of patients (13) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2007 Status change from recruiting to in progress.